Without hijacking the BOT thread and turning into a PAA thread, the timeline for PAA to complete their studies is likely less than 12 months. Have a read up on the phase2/3 trial info, very encouraging and only need $30m to complete them and aiming to have the drug on the market in <18 months.
Your point about sticking to a strategy is a sound one.
GLTA
MTC
Bot Chart, page-11583
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 32.0¢ | $1.776M | 5.339M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 118187 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 698385 | 8 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |